Home / Recalls / Direct Rx / D-0714-2022

D-0714-2022 Class II Terminated

Recalled by Direct Rx — Dawsonville, GA

Recall Details

Product Type
Drugs
Report Date
March 30, 2022
Initiation Date
December 7, 2021
Termination Date
October 5, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
312 bottles

Product Description

Diclofenac Sodium Topical Solution 1.5%, 150 mL, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534 Mfg. For SOLA Pharmaceuticals Baton Rouge, LA, NDC 61919-675-05

Reason for Recall

Defective Container: Leaking containers.

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: 24MA2010 Exp. 1/31/2023

Other recalls by Direct Rx

  • D-0567-2025 Class II — Duloxetine D/R, 20 mg, 30 Caps, 30-count bottle, RX Only, Packaged & Distributed (March 7, 2025)
  • D-0568-2025 Class II — Duloxetine D/R, 30 mg, 30 Caps, RX Only, Packaged as a) 30-count bottle NDC 6191 (March 7, 2025)
  • D-0364-2025 Class II — CIPROFLOXACIN OPHTH SOLUTION, 0.3% 5mL bottle, Rx Only, Generic for CILOXAN, Pac (January 31, 2025)
  • D-0041-2025 Class II — Ibuprofen 800mg, Generic for: Motrin, Each tablet contains: Ibuprofen, USP 800 m (August 9, 2024)
  • D-0509-2023 Class II — Alprazolam C-IV, 2 mg, 60 Tabs per bottle, Rx only, Packaged and Distributed By: (March 22, 2023)
  • D-0507-2023 Class II — Alprazolam C-IV, 0.5 mg, 30 Tabs per bottle, Rx only, Packaged and Distributed B (March 22, 2023)
  • D-0508-2023 Class II — Alprazolam C-IV, 1 mg, packaged in a) 30 Tabs per bottle, NDC 72189-213-30; b) 6 (March 22, 2023)
  • D-0481-2023 Class II — Glimepiride, USP, 2 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 6 (March 13, 2023)
  • D-0483-2023 Class II — Simvastatin, USP, 5 mg Tablets, Rx Only, Packaged as a 90-count bottle, NDC 6191 (March 13, 2023)
  • D-0484-2023 Class II — Simvastatin, USP, 10 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC (March 13, 2023)